Background—Hyperbaric oxygen (HBO) has been suggested to be beneficial in inflammatory bowel disease but the mechanisms responsible for its therapeutic effects have not been elucidated.
Aim—To assess the effect of HBO treatment on colonic damage in two models of experimental colitis, and to examine whether this effect is mediated by modulation of NO synthesis.
Methods—Colitis was induced by either flushing the colon with 2 ml 5% acetic acid or intracolonic administration of 30 mg trinitrobenzenesulphonic acid (TNB) dissolved in 0.25 ml 50% ethanol. Rats were exposed to HBO (100% oxygen at 2.4 atmosphere absolute) for one hour twice on the day of colitis induction and once daily thereafter. Control rats were treated only with acetic acid or TNB. Rats were killed 24 hours after acetic acid administration or one and seven days after TNB treatment. The colon was isolated, washed, and weighed, the lesion area was measured, and mucosal scrapings were processed for determination of myeloperoxidase (MPO) and NO synthase (NOS) activities, prostaglandin E2 (PGE2) and leukotriene B4 (LTB4) generation.
Results—In control rats exposed for seven days to HBO, colonic NOS activity was significantly decreased by 61%, compared with its activity in untreated rats (2.93 (0.17) nmol/g/min). HBO significantly reduced by 51 and 62% the extent of injury induced by acetic acid and TNB respectively. The protection provided by HBO was accompanied by a significant decrease in colonic weight, PGE2 generation, MPO, and NOS activities. In acetic acid colitis, LTB4 generation was also significantly decreased.
Conclusions—(1) HBO effectively decreases colitis induced by acetic acid and TNB. (2) The decreased NOS activity induced by HBO suggests that reduction in NO generation may be among the mechanisms responsible for the anti-inflammatory effect of HBO. (3) HBO may be considered in the treatment of patients with refractory inflammatory bowel disease.
- hyperbaric oxygen
- acetic acid colitis
- trinitrobenzenesulphonic acid colitis
- inflammatory bowel disease
Statistics from Altmetric.com
Hyperbaric oxygen (HBO) has been used as a safe and effective treatment in various clinical and experimental conditions1; it has been shown to be effective in air embolism decompression sickness and carbon monoxide poisoning. Its physiological effects on plasma oxygen content supported the use of HBO in patients with severe anaemia who cannot be transfused with blood and, despite less scientific support, favourable reports in various other indications are encouraging. Inhibition of neutrophil adherence and prevention of post-muscle crush vasodilation2 are among the other favourable effects ascribed to HBO. In the gut, HBO has been reported to ameliorate experimental small intestine ischaemia-reperfusion injury3 and to be of benefit in patients with severe perianal Crohn’s disease.4 ,5
The inflamed intestinal and colonic mucosa in inflammatory bowel disease (IBD) is infiltrated by neutrophils, macrophages, and lymphocytes. In the inflamed intestinal mucosa of patients with IBD, the generation of eicosanoids and leukotrienes by epithelial and inflammatory cells has been shown to be enhanced6 and has been suggested to have a role in the pathogenesis of the inflammatory response. In addition to oxygen free radicals generated by stimulated polymorphonuclear cells, eosinophils, xanthine oxidase, colonic bacteria, and epithelial lipoxygenase, all of which are present in the inflamed bowel of patients with IBD, intestinal NO generation is also increased in models of experimental colitis and in patients with IBD.7 NO contributes to tissue injury by reacting with superoxide; NO and superoxide are simultaneously synthesised by activated macrophages and inflammatory neutrophils. The product of this reaction is peroxynitrite, a powerful oxidant shown by us to induce severe colonic inflammation.8 There is no definite indication as to the relative contribution of each of the mediators to the inflammatory cascade, but it is conceivable that free radicals, NO, and superoxide are the final agents responsible for the infliction of tissue damage. The amelioration of experimental colitis induced byN G-nitro-l-arginine methyl ester (L-NAME),9 an inhibitor of NO synthase (NOS), and by nitroxides,10 potent scavengers of oxygen free radicals, indicates the pivotal role of free radicals in the pathogenesis of tissue damage in general and colonic injury in particular.
In view of the favourable response to HBO treatment of perianal Crohn’s disease, the purpose of this study was to assess the effect of HBO treatment on the extent of tissue damage in two models of experimental colitis. Moreover, since hyperbaric oxygenation has been shown to reduce transcription of the NOS gene and peroxynitrite synthesis of mouse peritoneal macrophages,11 we tested its effects on the inflammatory mediators and NOS activity in experimental colitis induced by acetic acid and trinitrobenzenesulphonic acid (TNB).
Materials and Methods
l-Arginine, l-citrulline, L-NAME, NADPH, dithiothreitol, phenylmethanesulphonyl fluoride, EDTA, and EGTA were purchased from Sigma Chemical Co. (St Louis, Missouri, USA), Dowex AG50W-X8 (sodium form, 100–200 mesh) and Tris base (electrophoresis grade) from Bio-Rad Laboratories (Richmond, California, USA), and aquasol-2 from DuPont/NEN Research Products (Bad Hamburg, Germany).
Male Sprague-Dawley rats, weighing 200–250 g and fed ad libitum, were used in all studies.
ACETIC ACID INDUCED COLITIS
Acetic acid colitis was induced under light anaesthesia. A midline abdominal incision was made and the colon isolated; 2 ml 5% acetic acid was injected into the lumen of the colon at its proximal part through a 25 gauge needle followed by 3 ml air, which cleared most of the acetic acid from the colon. The midline incision was closed. After 24 hours the rats were killed and their colons removed.
TNB INDUCED COLITIS
Colitis was induced under light anaesthesia by a single intracolonic administration of 0.25 ml 50% ethanol containing 30 mg TNB. The solution was introduced via a catheter of 0.3 mm outer diameter placed 7 cm from the anus. The rats were killed 24 hours or seven days after induction of colonic injury and their colons removed. These time intervals represent the acute and chronic responses to TNB.
The effects of HBO therapy (100% oxygen at 2.4 atmosphere absolute (ATA)) were studied in rats in which colitis had been induced and in control rats. The transparent HBO chamber used is identical with that used by Tibbles and Edelsberg1 and is large enough to admit an adult person. Both experimental and control rats were placed in this large chamber in the original cages (five rats per cage). Ten rats were exposed in each treatment. Rats were exposed to HBO for one hour twice at six hour intervals on the day of colitis induction and once daily thereafter until they were killed. All rats were killed by cervical dislocation. The colons were isolated and a 10 cm segment of the distal colon proximal to the anus was resected, its lumen rinsed with ice cold saline and weighed. Mucosal damage in the 10 cm distal segment was measured macroscopically by two blinded observers using a stereomicroscope and scored by multiplying the length (mm) and width (mm) of each lesion. For each rat the total score was determined by summing the ulcer scores (mm2). Interobserver variation was 7%. Tissue samples were obtained for histological analysis and the remaining mucosa was scraped and processed for determination of eicosanoid generation and myeloperoxidase (MPO) and NOS activities.
DETERMINATION OF NOS ACTIVITY
NOS activity was monitored by measuring the conversion ofl-[3H]arginine into citrulline as described by Bush et al.12 Mucosal scrapings (100 mg) were homogenised for 30 seconds at 4°C with a Polytron (Kinematica GmbH, Kriens-Luzern, Switzerland) in 0.9 ml ice cold 50 mmol/l Tris/HCl (pH 7.4) containing 0.1 mmol/l EDTA, 0.1 mmol/l EGTA, 0.5 mmol/l dithiothreitol, and 1 mmol/l phenylmethanesulphonyl fluoride. Homogenates were centrifuged at 20 000 g for 60 minutes at 4°C and the supernatant was used as the source of NOS. Enzymic reactions were conducted at 37°C in 50 mmol/l Tris/HCl (pH 7.4) containing 100 μmol/l l-arginine, 100 μmol/l NADPH, 2 mmol/l CaCl2, 0.2–0.4 mg supernatant proteins, and about 200 000 dpm l-[2,3,4,5-3H]arginine hydrochloride (77 Ci/mmol; Amersham International, Amersham, Bucks, UK) to a final volume of 100 μl. Enzyme reactions were also carried out in the absence of Ca2+ and in the presence of EGTA 1 mmol/l. Reactions were terminated by the addition of 2.0 ml ice cold stop buffer (20 mmol/l sodium acetate (pH 5.5), 1 mmol/ll-citrulline, 2 mmol/l EDTA, and 0.2 mmol/l EGTA). Citrulline concentration was determined by applying the samples (2.0 ml) prepared as described above to columns (1 cm diameter) containing 1 ml Dowex AG50W-X8 (sodium form), which had been pre-equilibrated with stop buffer. Columns were eluted with 4 × 1.0 ml water collected into scintillation vials. Opti-fluor (10 ml; Packard, Meridien, Connecticut, USA) was added to each vial and samples were counted in a Packard Tri-Carb liquid scintillation spectrometer (Amana, Iowa, USA). Citrulline was recovered in the first 4.0 ml of the Dowex column eluate to the extent of 96 (2)%.
DETERMINATION OF MPO ACTIVITY
Colonic mucosal scrapings (200 mg) were homogenised (3 × 30 seconds) at 4°C in a Polytron in 1.0 ml ice cold 0.5% hexadecyltrimethylammonium bromide in 50 mmol/l phosphate buffer (pH 6.0). The Polytron probe was rinsed twice with 1.0 ml of the buffer and the washings were added to the homogenate. The homogenate was then sonicated for 10 seconds, freeze-thawed three times, and centrifuged for 15 minutes at 40 000 g. An aliquot of the supernatant was taken for determination of enzyme activity as described by Bradleyet al.13
DETERMINATION OF EICOSANOID GENERATION
A 150 mg sample of mucosa was placed in a preweighed tube containing 1.0 ml phosphate buffer (50 mmol/l, pH 7.4). The mucosa was minced with scissors and centrifuged in an Eppendorf centrifuge (Hamburg, Germany) for 10 seconds. The pellet was resuspended in 1.0 ml of the above buffer and incubated for one minute in a vortex mixer; 10 μg indomethacin was added, and the tubes were centrifuged for 60 seconds. The supernatants were kept at −20°C until radioimmunoassays (RIAs) were performed. The ability of the mucosa to generate leukotriene B4 (LTB4) was expressed as ng/g of wet tissue weight.
MEASUREMENT OF LTB4
LTB4 immunoreactivity was determined using an RIA kit (TRK 940; Amersham). The assay combines the use of a high specific radioactivity LTB4 tracer, an antiserum specific for LTB4 (cross reactivity 100%), and a leukotriene standard (range 1.6–200 pg/tube). The specific binding of tracer is 42.5% and non-specific binding is 2.4%. A 50% B/Bo displacement is obtained with 15 pg/tube LTB4 and 90% with 2.2 pg/tube.
MEASUREMENT OF PGE2
PGE2 generation was determined by RIA, as previously described.14
Sections of colon were obtained from the same areas of the large intestine from four representative animals in each of the treatment groups during autopsy. They were fixed in phosphate buffered formaldehyde, embedded in paraffin, and routine 5 μm sections were prepared. Tissues were routinely stained with haematoxylin and eosin and were evaluated by light microscopy by a pathologist unaware of the experiments being performed.
Data are expressed as mean (SEM). Statistical analysis for significant differences was performed in all instances by Student’st test for unpaired data and the non-parametric Mann-Whitney U test.
EFFECT OF ACETIC ACID AND TNB ON THE RAT COLON
The wet weight of the 10 cm long distal colonic segment, mucosal eicosanoid generation, and MPO and NOS activities in rats treated with acetic acid or TNB but not exposed to HBO were significantly higher than in control untreated rats (table 1).
EFFECT OF HBO TREATMENT ON THE COLON OF CONTROL RATS
HBO treatment did not affect body weight. The body weight of control rats not exposed to HBO was 200 (5) g (n = 12), 207 (3) g (n = 10), and 249 (12) g (n = 6) on day 0 and after one and seven days. In rats exposed to HBO the body weights were 202 (5) g (n = 10), 210 (4) g (n = 10), and 253.0 (4.5) g (n = 8) respectively. In control rats exposed to HBO for one or seven days, the wet weight of the 10 cm colonic segment and MPO activity were similar to those in untreated rats. After seven days of HBO treatment, colonic NOS activity was significantly decreased. Colonic PGE2 generation was significantly decreased after the first day of HBO treatment, whereas at seven days, both PGE2 and LTB4 generation were similar to that in control untreated rats (table2).
Histological examination of sections of the large intestine of six normal rats treated for 24 hours with HBO showed normal colonic mucosa in all of them. After seven days of HBO treatment the mucosa was normal in three of the six rats examined, but in the other three there were small superficial ulcerations with no reactive infiltrate.
EFFECT OF HBO ON ACETIC ACID INDUCED COLITIS
At 24 hours after administration of acetic acid the colon was haemorrhagic and inflamed. Exposure to HBO significantly reduced by half the extent of the acetic acid induced lesion area. In HBO treated rats the wet weight was also significantly decreased compared with the wet weight of the colonic segment in rats treated with acetic acid only (fig 1).
Mucosal MPO activity in control and acetic acid treated rats was 1.26 (0.14) (n = 12) and 5.60 (0.85) (n = 12) units/g respectively. In rats treated with acetic acid and HBO, MPO activity was significantly reduced to 3.2 (0.3) units/g, almost half of its activity in rats treated with acetic acid only. In acetic acid treated rats, both PGE2 and LTB4 generation was increased compared with that in normal untreated rats (tables 1 and 2). Exposure of acetic acid treated rats to HBO resulted in an almost 50% decrease in PGE2 and LTB4 generation (table 3). In acetic acid treated rats, colonic mucosal NOS activity—7.10 (1.05) (n = 12) nmol/g/min, which is more than twofold higher than in control rats—was significantly reduced in acetic acid treated rats exposed to HBO (table 3).
Histological examination showed that in all rats treated with acetic acid there were widespread mucosal ulcerations with significant oedema of the submucosa, accompanied by inflammatory cell infiltrate involving all layers of the bowel wall. In two of seven rats treated with acetic acid and HBO there were only minute superficial ulcerations involving not more than one third of the mucosal width and accompanied by minimal inflammatory cell infiltrate (fig 2A). In the other five rats treated with acetic acid and HBO the histological findings were similar to those in rats treated with acetic acid only. In these rats there were wide mucosal ulcerations involving the whole mucosal width with significant inflammatory cell infiltrate (fig 2B).
EFFECT OF HBO ON TNB INDUCED COLITIS
Intracolonic administration of TNB/ethanol resulted in extensive haemorrhagic and ulcerative damage to the colon. By 24 hours the lesion area was 1004 (81) mm2/rat (n = 14). Seven days after damage induction, the lesion area was 1053 (182) mm2. Exposure to HBO induced a significant decrease of 55% in the lesion area observed 24 hours after damage induction. Seven days after induction of damage the decrease in the extent of the damage averaged 63% in HBO treated rats. The amelioration of the severity of the inflammatory response in HBO treated rats was also reflected by the difference in the wet weight of the 10 cm long distal colonic segment (fig 3).
MPO activity in rats treated with TNB and HBO was significantly lower than in rats treated with TNB only. One and seven days after TNB treatment, colonic NOS activity was significantly increased compared with that in control rats. In those treated with TNB and HBO, colonic NOS activity was significantly lower than in TNB treated rats one and seven days after treatment (table 4). PGE2 generation was significantly reduced in rats treated with TNB and HBO, whereas mucosal LTB4 generation was not significantly affected by HBO treatment (table 4).
Histological examination of mucosa taken 24 hours after treatment with TNB showed widespread haemorrhagic ulcerations of the whole mucosal width with significant inflammatory cell infiltrate and submucosal oedema. In three of eight rats treated with TNB and HBO, after 24 hours there were only a few superficial mucosal ulcerations involving one third of the mucosa with slight oedema, whereas the rest of the segment was normal (fig 4A). In the other five rats treated with TNB and HBO, after 24 hours there were widespread ulcerations with inflammatory cell infiltrate and submucosal oedema (fig 4B). Seven days after treatment with TNB and HBO, in eight of ten rats, the histological findings were similar to those in rats treated with TNB only. There was widespread ulceration with granulation of tissue and inflammatory cell infiltrate. In only two rats treated with TNB and HBO was the mucosa normal after seven days.
In the present study the possible application of HBO as a novel therapeutic approach for amelioration of the inflammatory response in patients with IBD was found to be very effective in decreasing tissue damage in two models of experimental colitis. In addition, decreased PGE2 generation and NOS activity were found to be induced by hyperbaric oxygenation, suggesting that they may be involved in the therapeutic effects in experimental colitis and patients with IBD.
HBO has been described as a therapy in search of diseases.15 Although many of its clinical uses are controversial, its application has been evaluated in the search for treatments for pathological conditions, especially those of unknown aetiology. The clinical use of HBO therapy has been reviewed recently.1 HBO, which is 100% oxygen at two to three times the atmospheric pressure at sea level, may result in increased Pao 2 in excess of 2000 mm Hg and tissue Po 2 of almost 400 mm Hg. Such excessive Po 2 may have a number of beneficial biochemical, cellular, and physiological effects, among which are alleviation of tissue hypoxia and restoration of tissue defence against bacterial infection. HBO is bactericidal for certain anaerobic pathogens and suppresses clostridial production of α-toxin. It promotes wound healing and mitigates post-ischaemic-reperfusion injury, probably by suppressing neutrophil adherence and production of free radicals.
HBO treatment is the definitive treatment (often life-saving) for decompression sickness after underwater diving accidents, arterial gas embolism, or carbon monoxide poisoning. HBO has also been used with varying degrees of success to promote healing of tissues damaged by radiation, infection, and mechanical or thermal trauma. In addition, HBO is a useful adjunct in the management of problem wounds complicating diabetes mellitus and vascular diseases. When used with pressures of 3 atm or less in sessions of 120 minutes or less, HBO treatment is safe. If these limits are exceeded, it may cause generalised seizures and temporary impairment of inner ear function.
In view of the various positive therapeutic effects of HBO, it was also used for patients suffering from severe perianal Crohn’s disease.4 ,5 In the present study we tried to substantiate the positive anti-inflammatory effects of HBO in models of experimental colitis and to elucidate its effects on the inflammatory mediators involved in the pathogenesis of experimental colitis.
Models of experimental colitis differ fundamentally from human IBD. However, irrespective of their cause, in the experimental model the inflammatory response resembles, in many aspects, the sequence of events in IBD. HBO was found in the present study to significantly decrease the extent of tissue damage in both acetic acid- and TNB-induced colitis. A significant effect was already observed 24 hours after induction of the injury and, in the TNB model, also after seven days. The decrease in tissue damage was apparent macroscopically by measuring the lesion area and also the colonic wet weight. Wet weight has been found to be a very accurate, sensitive, and reliable marker of tissue damage in models of experimental colitis.16 The decrease in the extent of tissue injury was less pronounced histologically. In both the TNB and acetic acid models, at 24 hours, an effect of HBO on the extent of tissue injury was apparent on histological examination only in one quarter to one third of the treated animals. At seven days, in the TNB model, a beneficial effect of HBO was observed histologically in only 20% of the animals. A lack of correlation between the macroscopical and histological effects of pharmacological manipulation of colonic inflammation in models of experimental colitis has been reported previously. In rat models of colitis induced by iodoacetamide,17 acetic acid or TNB,9 the morphological effects of L-NAME and nitroxide were also less remarkable than their effects on the macroscopic appearance of the mucosa. It therefore seems that, in models of colonic inflammation, irrespective of the therapeutic modality, HBO included, the beneficial histological effect is less pronounced and lags after the macroscopic effects. As in the present study, most time courses in models of experimental colitis have apparently been too short to allow a significant histological effect.
A possible mechanism to explain the effect of HBO on the extent of tissue injury in these models of experimental colitis is an effect on the inflammatory mediators involved in the pathogenesis of tissue inflammation. The effects of HBO treatment on mucosal eicosanoid generation and MPO and NOS activities were therefore evaluated. MPO activity generated by granulocytes is stimulated both in acetic acid and TNB colitis.9 In the present study MPO activity was found to be significantly decreased in the acetic acid model and in TNB induced colitis after seven days of exposure to HBO. The decrease in the extent of inflammation is accompanied, as in the other pharmacological manipulations, by a decrease in MPO activity.
Amelioration of tissue injury in both models was also accompanied by a significant decrease in mucosal NOS activity. Most of the colonic NOS activity in all treatment groups at the various time intervals was independent of calcium and thus represents the inducible form. In both models of colitis, NO generation by stimulated NOS activity has been shown previously to be enhanced.7 The enhanced NO generation may make an important contribution to the pathogenesis of the damage, as indicated by the impressive amelioration of tissue damage induced by specific inhibition of NOS activity in this9 and other17 models of experimental colitis.
The decrease in mucosal NOS activity may be secondary to the decrease in the number of inflammatory cells and/or the decrease in their activity after HBO treatment. Alternatively, the decrease in mucosal NOS activity may be a primary event whereby HBO exerts its beneficial effects. This possibility is supported by the observation in the present study that seven days exposure of control untreated rats to HBO also resulted in significant suppression of this enzyme activity, whereas MPO activity was not affected. No effect of one day of HBO treatment of control rats on NOS activity was observed, probably because NOS activity is not induced in control rats and a short HBO treatment is not powerful enough.
It has been shown previously that, in models of experimental colitis, mucosal PGE2 and LTB4 generation are enhanced, and it has been suggested that they may contribute to the pathogenesis of tissue damage. Amelioration of the extent of tissue injury by HBO treatment is accompanied by significant decreases in PGE2generation in both models and, in the acetic acid model, also by a significant decrease in mucosal LTB4 generation. The involvement and role of mucosal eicosanoids differ with respect to the specific injurious agent. A lack of correlation between histological improvement and mucosal LTB4 generation has also been reported for iodoacetamide induced colitis.17 It is therefore unlikely that a specific effect of HBO on LTB4generation contributes to its effects in TNB induced colitis, whereas in the acetic acid model, this may be one of the mechanisms contributing to its effects. In the colon, PGE2 is regarded as one of the pro-inflammatory mediators; its role in other organs18 and its decrease after HBO treatment suggest that it may contribute to the anti-inflammatory effects of HBO. Similarly, inhibition of PGE2 generation by COX-2 inhibitors may be of value in the treatment of colonic inflammation.
Another possible mechanism to explain the beneficial effect of HBO may involve the superficial mucosal damage observed in control rats treated for seven days with HBO. In the upper gut, superficial mucosal injury induced by mild irritants has been shown to protect the mucosa against subsequent injury, a process termed adaptive cytoprotection.19 Similar mechanisms may exist in the colon and may explain how HBO treatment that causes superficial ulceration protects against more severe injury.
In conclusion, in the present study, HBO treatment was shown to modulate the extent of tissue injury in two models of experimental colitis. This effect is accompanied by a significant decrease in NOS activity, which may be among the mechanisms to explain the benefits of HBO treatment in experimental colitis and maybe even in human IBD.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.